{"id":"https://openalex.org/W2412802484","doi":null,"title":"New ocular therapeutics: a view from the patenting perspective.","display_name":"New ocular therapeutics: a view from the patenting perspective.","alternate_titles":[],"publication_year":2007,"publication_date":"2007-01-01","ids":{"openalex":"https://openalex.org/W2412802484","mag":"2412802484","pmid":"https://pubmed.ncbi.nlm.nih.gov/17187313"},"language":"en","primary_location":{"id":"pmid:17187313","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17187313","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"IDrugs : the investigational drugs journal","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2412802484"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009788880","display_name":"Hermann AM Mucke","orcid":"https://orcid.org/0000-0002-1491-6250","observed_orcids":["https://orcid.org/0000-0002-1491-6250"]},"institutions":[{"id":"https://openalex.org/I4210116138","display_name":"Herry Consult (Austria)","ror":"https://ror.org/02crf0z25","country_code":"AT","type":"company","lineage":["https://openalex.org/I4210116138"]}],"countries":["AT"],"is_corresponding":true,"raw_author_name":"Hermann A M Mucke","raw_affiliation_strings":["HM Pharma Consultancy, Enenkelstrasse 28/32, A-1160 Wien, Austria. h.mucke@hmpharmacon.com","HM Pharma Consultancy, Enenkelstrasse 28/32, A-1160 Wien, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HM Pharma Consultancy, Enenkelstrasse 28/32, A-1160 Wien, Austria. h.mucke@hmpharmacon.com","institution_ids":["https://openalex.org/I4210116138"]},{"raw_affiliation_string":"HM Pharma Consultancy, Enenkelstrasse 28/32, A-1160 Wien, Austria","institution_ids":["https://openalex.org/I4210116138"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5009788880"],"corresponding_institution_ids":["https://openalex.org/I4210116138"],"apc_list":null,"apc_paid":null,"fwci":0.2199,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.46409482,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"10","issue":"1","first_page":"37","last_page":"41"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.8988999724388123,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.8988999724388123,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10856","display_name":"Intellectual Property and Patents","score":0.030700000002980232,"subfield":{"id":"https://openalex.org/subfields/1405","display_name":"Management of Technology and Innovation"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T14384","display_name":"Ophthalmology and Visual Health Research","score":0.010200000368058681,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ocular-therapeutics","display_name":"ocular therapeutics","score":0.9739999771118164},{"id":"https://openalex.org/keywords/ophthalmic-drug-development","display_name":"ophthalmic drug development","score":0.8090000152587891},{"id":"https://openalex.org/keywords/patents","display_name":"patents","score":0.48100000619888306},{"id":"https://openalex.org/keywords/drug-delivery","display_name":"drug delivery","score":0.625},{"id":"https://openalex.org/keywords/dry-eye-disease","display_name":"dry eye","score":0.996999979019165},{"id":"https://openalex.org/keywords/ocular-infection","display_name":"ocular infection","score":0.9929999709129333},{"id":"https://openalex.org/keywords/glaucoma","display_name":"glaucoma","score":0.7950000166893005},{"id":"https://openalex.org/keywords/age-related-macular-degeneration","display_name":"age-related macular degeneration","score":1.0},{"id":"https://openalex.org/keywords/rna-interference","display_name":"RNA interference","score":0.8479999899864197},{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.7179999947547913}],"concepts":[{"id":"https://openalex.org/C12713177","wikidata":"https://www.wikidata.org/wiki/Q1900281","display_name":"Perspective (graphical)","level":2,"score":0.5970137715339661},{"id":"https://openalex.org/C2776403814","wikidata":"https://www.wikidata.org/wiki/Q27429789","display_name":"Macular degeneration","level":2,"score":0.5247210264205933},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5181935429573059},{"id":"https://openalex.org/C119767625","wikidata":"https://www.wikidata.org/wiki/Q618211","display_name":"Optometry","level":1,"score":0.4624398648738861},{"id":"https://openalex.org/C2778527774","wikidata":"https://www.wikidata.org/wiki/Q159701","display_name":"Glaucoma","level":2,"score":0.438515841960907},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.4179121255874634},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.22412261366844177},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.06668707728385925}],"mesh":[{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005123","descriptor_name":"Eye","qualifier_ui":"Q000033","qualifier_name":"anatomy & histology","is_major_topic":false},{"descriptor_ui":"D005128","descriptor_name":"Eye Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005901","descriptor_name":"Glaucoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008268","descriptor_name":"Macular Degeneration","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010330","descriptor_name":"Patents as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015352","descriptor_name":"Dry Eye Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D034741","descriptor_name":"RNA, Small Interfering","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:17187313","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17187313","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"IDrugs : the investigational drugs journal","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2411766476","https://openalex.org/W2038115242","https://openalex.org/W3049167625","https://openalex.org/W3029095168","https://openalex.org/W2418496978","https://openalex.org/W7023507238","https://openalex.org/W2056008826","https://openalex.org/W2334007458","https://openalex.org/W3128904941","https://openalex.org/W4290970981"],"abstract_inverted_index":{"This":[0],"feature":[1],"article":[2],"provides":[3],"an":[4],"overview":[5],"of":[6,50,79,84],"the":[7,24,44,48,51],"newest":[8],"therapeutic":[9],"developments":[10],"for":[11,54],"ocular":[12,66],"diseases,":[13],"based":[14],"on":[15],"patents":[16],"and":[17,68,71],"patent":[18],"applications":[19],"that":[20],"were":[21],"published":[22],"in":[23,40,87],"12-month":[25],"period":[26],"from":[27],"November":[28],"2005":[29],"to":[30,35],"October":[31],"2006.":[32],"In":[33],"contrast":[34],"peer-reviewed":[36],"literature":[37],"covering":[38],"breakthroughs":[39],"basic":[41],"science":[42],"research,":[43,89],"patenting":[45],"perspective":[46],"discloses":[47],"intentions":[49],"pharmaceutical":[52],"industry":[53],"imminent":[55],"drug":[56,61],"development.":[57],"Selected":[58],"documents":[59],"describing":[60],"delivery,":[62],"dry":[63],"eye":[64],"syndrome,":[65],"infections":[67],"lesions,":[69],"glaucoma":[70],"age-related":[72],"macular":[73],"degeneration":[74],"are":[75],"discussed.":[76],"The":[77],"role":[78],"RNA":[80],"interference,":[81],"which":[82],"is":[83,90],"particular":[85],"interest":[86],"ophthalmology":[88],"also":[91],"highlighted.":[92]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2412802484","counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}
